Navigation Links
BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock
Date:5/12/2009

SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has commenced a public offering of 14,000,000 shares of its common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $600.0 million unsecured line of credit and for other general corporate and working capital purposes. All of the shares will be offered by the company.

BioMed also expects to grant the underwriters a 30-day option to purchase an additional 2,100,000 shares to cover over-allotments, if any. Raymond James & Associates, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. Incorporated, UBS Securities LLC, Wachovia Capital Markets, LLC and Credit Suisse Securities (USA) LLC are the joint book-running managers for the offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the offered shares, nor shall there be any sale of such shares in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or other jurisdiction. The offering of BioMed's common stock will be made only by means of a prospectus and a related prospectus supplement, copies of which, when available, may be obtained by contacting Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, or by calling toll-free at 1 (800) 248-8863; KeyBanc Capital Markets Inc., 800 Superior Avenue, 17th Floor, Cleveland, Ohio 44114, telephone: 216-443-2370; Morgan Stanley & Co. Incorporated, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at '/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Response Biomedical Announces Proposed Unit Offering
2. BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
3. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
4. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
5. Four legendary LA BioMed physician-researchers honored
6. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
7. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
8. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
9. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
10. Response Biomedical Corporation Reports 2008 Financial Results
11. Advance Internet Launches HireBioMedical.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Against Insurer-favored ,Cost Solution,: Selling Policies That Amount To ... WASHINGTON , Feb. 9 ... regulators with its premium hikes of up to 39% ... face of questions from the White House and an ... state lawmakers should act to regulate health insurance premiums ...
(Date:2/9/2010)... University,s Slone Epidemiology Center have found a direct ... type 2 diabetes in African American women. The ... Journal of Epidemiology , is the first prospective ... status and incidence of type 2 diabetes in ... , Type 2 diabetes is estimated to affect ...
(Date:2/9/2010)... 8, 2010- The research group of Dr. Franois Robert, ... Montral (IRCM), in collaboration with the team of Dr. ... Toronto) accomplished a technical breakthrough: they mapped all the ... Saccharomyces cerevisiae . The method used by the ... been published online today in the scientific journal ...
(Date:2/9/2010)... Cerebral palsy (CP) has increased in infants born prematurely ... from Loyola University Health System (LUHS). These findings were ... for Maternal-Fetal Medicine in Chicago. They also were published ... of Obstetrics & Gynecology . , Researchers reported that ... in the umbilical cord. This inflammation is more common ...
(Date:2/9/2010)... The Quantum Foundation is proud to be partners ... Palm Beach County that will help kids and their ... Foundation (RWJF) recently announced a $360,000 grant to ... foods for children and families in Lake Worth , ... rigorous selection process that drew more than 500 proposals from ...
Breaking Medicine News(10 mins):Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3Health News:Neighborhood socioeconomic status and diabetes 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:Incidence of cerebral palsy on rise in US 2Health News:Planting Seeds to Fight Childhood Obesity 2
... 2008 A 115-year-old woman who remained mentally alert ... little or no evidence of Alzheimer,s disease, according to ... Aging ( http://neurobiologyofaging.org/ ). , The findings question the ... will inevitably develop, if people live long enough. ...
... Cancer patients who attended a specialist nurse clinic rather ... from longer, more frequent consultations and good symptom management, ... the Journal of Clinical Nursing. , And because ... 83 per cent of the consultations without referring issues ...
... and MacroArray,Technologies, LLC have entered into a development ... phone communication,technology and MacroArray,s urine diagnostic test for ... at risk of developing prostate cancer, but,unfortunately not ... simplify and expand,the use of low cost wireless ...
... June 9 ATS Medical, Inc.,(Nasdaq: ... cardiac,surgery products and services, today noted that ... experience with ATS Medical products and related,procedures ... International,Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) ...
... (NASDAQ: QLTI; TSX:,QLT) announced today that QLT USA, ... purchase agreement with Allergan Sales, LLC, a,wholly-owned subsidiary ... fully divest QLT,s,worldwide rights to Aczone(R), a prescription ... for the treatment of acne vulgaris. Under the,terms ...
... Change is Key Focus ... for AHIP 2008 Session, ... solutions for health payers, today announced that it,will host a symposium ... The Friday, June 20 breakfast meeting session,will provide health payer executives ...
Other Medicine News:Health News:World's oldest woman had normal brain 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Gentag, Inc. and MacroArray Technologies Join Forces 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5Health News:Adaptis Seminar to Provide Strategies for Managing Market Transformations 2
(Date:2/9/2010)... Feb. 9 Palatin Technologies, ... the completion of first cohort dosing in a ... treatment for sexual dysfunction.  The primary endpoint in ... pressure effects of subcutaneous bremelanotide in men between ... also evaluate consistency of plasma exposure of bremelanotide ...
(Date:2/9/2010)... LAUSANNE , Switzerland , February ... Swiss-based global biopharmaceutical group of companies with,a ... that target unmet medical,needs, today announced the ... for the development, manufacture and commercialisation of ... inhibitor with a,potent anti-hepatitis C virus (HCV) ...
(Date:2/8/2010)... Calif. , Feb. 8 PreXion, ... quality 3D Cone Beam Imaging systems for dentistry, today ... as Director of Marketing. ,, PreXion President/COO ... Keith on our senior management team and I look ... extensive sales and marketing leadership, experience and success in ...
Breaking Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3PreXion, Inc. Announces Appointment of Director of Marketing 2Icahn Indicates That Biogen Board Refuses To Close Polls 12450 1MDCT angiography leads to successful treatment of severely blocked arteries in the legs 47804 1Biologists consider unifying framework to explain evolutionary puzzles 8709 1Biologists consider unifying framework to explain evolutionary puzzles 8709 2
... Inc. (OTC Bulletin Board: PLCSF), a company focused on ... that the first data from its pilot safety trial ... at the American College of Cardiology Annual Conference, on ... Florida. The poster will be presented by Dr. ...
... Abstracts Will Be Featured at Annual Kidney Care MeetingEL ... provider of kidney care services for those diagnosed with ... DaVita Clinical Research(R), today announced that company representatives will ... Spring Clinical Meetings scheduled for March 25-29, 2009 in ...
Other Medicine Technology:RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 2RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 2DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 4DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: